Health and economic impact of HPV 16 and 18 vaccination and cervical cancer screening in India View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2008-07

AUTHORS

M Diaz, J J Kim, G Albero, S de Sanjosé, G Clifford, F X Bosch, S J Goldie

ABSTRACT

Cervical cancer is a leading cause of cancer death among women in low-income countries, with approximately 25% of cases worldwide occurring in India. We estimated the potential health and economic impact of different cervical cancer prevention strategies. After empirically calibrating a cervical cancer model to country-specific epidemiologic data, we projected cancer incidence, life expectancy, and lifetime costs (I$2005), and calculated incremental cost-effectiveness ratios (I$/YLS) for the following strategies: pre-adolescent vaccination of girls before age 12, screening of women over age 30, and combined vaccination and screening. Screening differed by test (cytology, visual inspection, HPV DNA testing), number of clinical visits (1, 2 or 3), frequency (1 x , 2 x , 3 x per lifetime), and age range (35-45). Vaccine efficacy, coverage, and costs were varied in sensitivity analyses. Assuming 70% coverage, mean reduction in lifetime cancer risk was 44% (range, 28-57%) with HPV 16,18 vaccination alone, and 21-33% with screening three times per lifetime. Combining vaccination and screening three times per lifetime provided a mean reduction of 56% (vaccination plus 3-visit conventional cytology) to 63% (vaccination plus 2-visit HPV DNA testing). At a cost per vaccinated girl of I$10 (per dose cost of $2), pre-adolescent vaccination followed by screening three times per lifetime using either VIA or HPV DNA testing, would be considered cost-effective using the country's per capita gross domestic product (I$3452) as a threshold. In India, if high coverage of pre-adolescent girls with a low-cost HPV vaccine that provides long-term protection is achievable, vaccination followed by screening three times per lifetime is expected to reduce cancer deaths by half, and be cost-effective. More... »

PAGES

6604462

Identifiers

URI

http://scigraph.springernature.com/pub.10.1038/sj.bjc.6604462

DOI

http://dx.doi.org/10.1038/sj.bjc.6604462

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1038043563

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/18612311


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1117", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Public Health and Health Services", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cost-Benefit Analysis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "DNA, Viral", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Human papillomavirus 16", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Human papillomavirus 18", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "India", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Mass Screening", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Models, Economic", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Models, Statistical", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Papillomavirus Infections", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Papillomavirus Vaccines", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Risk Factors", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Stochastic Processes", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Uterine Cervical Neoplasms", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Vaccination", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Autonomous University of Barcelona", 
          "id": "https://www.grid.ac/institutes/grid.7080.f", 
          "name": [
            "Unit of Infections and Cancer (UNIC), Cancer Epidemiology Research Programme, Catalan Institute of Oncology (ICO), Av. Gran Via, s/n km. 2.7, 08907 L'Hospitalet de Llobregat, Barcelona, Spain", 
            "Department of Health Policy and Management, Program in Health Decision Science, Harvard School of Public Health, 718 Huntington Avenue, 2nd Floor; Boston, MA 02115, USA", 
            "Department of Paediatrics, Obstetrics, Gynaecology and Preventive Medicine, Program in Public Health and the Methodology of Biomedical Research, Universitat Aut\u00f3noma de Barcelona (UAB), Bellaterra 08193 (Cerdanyola del Vall\u00e8s), Spain"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Diaz", 
        "givenName": "M", 
        "id": "sg:person.0622362671.40", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0622362671.40"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Department of Health Policy and Management, Program in Health Decision Science, Harvard School of Public Health, 718 Huntington Avenue, 2nd Floor; Boston, MA 02115, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kim", 
        "givenName": "J J", 
        "id": "sg:person.010413204164.20", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010413204164.20"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Institut Catal\u00e0 d'Oncologia", 
          "id": "https://www.grid.ac/institutes/grid.418701.b", 
          "name": [
            "Unit of Infections and Cancer (UNIC), Cancer Epidemiology Research Programme, Catalan Institute of Oncology (ICO), Av. Gran Via, s/n km. 2.7, 08907 L'Hospitalet de Llobregat, Barcelona, Spain"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Albero", 
        "givenName": "G", 
        "id": "sg:person.01001145477.44", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01001145477.44"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Institut d'Investigaci\u00f3 Biom\u00e9dica de Bellvitge", 
          "id": "https://www.grid.ac/institutes/grid.418284.3", 
          "name": [
            "Unit of Infections and Cancer (UNIC), Cancer Epidemiology Research Programme, Catalan Institute of Oncology (ICO), Av. Gran Via, s/n km. 2.7, 08907 L'Hospitalet de Llobregat, Barcelona, Spain", 
            "IDIBELL, CIBERESP, Barcelona, Spain"
          ], 
          "type": "Organization"
        }, 
        "familyName": "de Sanjos\u00e9", 
        "givenName": "S", 
        "id": "sg:person.015452603277.16", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015452603277.16"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "International Agency For Research On Cancer", 
          "id": "https://www.grid.ac/institutes/grid.17703.32", 
          "name": [
            "Infections and Cancer Epidemiology Group, Epidemiology and Biology Cluster, International Agency for Research on Cancer (IARC), 150 Cours Albert Thomas, Lyon CEDEX 08 69372, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Clifford", 
        "givenName": "G", 
        "id": "sg:person.0725020131.22", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0725020131.22"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Institut Catal\u00e0 d'Oncologia", 
          "id": "https://www.grid.ac/institutes/grid.418701.b", 
          "name": [
            "Unit of Infections and Cancer (UNIC), Cancer Epidemiology Research Programme, Catalan Institute of Oncology (ICO), Av. Gran Via, s/n km. 2.7, 08907 L'Hospitalet de Llobregat, Barcelona, Spain"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Bosch", 
        "givenName": "F X", 
        "id": "sg:person.012346261072.25", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012346261072.25"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Department of Health Policy and Management, Program in Health Decision Science, Harvard School of Public Health, 718 Huntington Avenue, 2nd Floor; Boston, MA 02115, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Goldie", 
        "givenName": "S J", 
        "id": "sg:person.0670476071.20", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0670476071.20"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1016/j.vaccine.2008.04.053", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1005773753"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0140-6736(07)61195-7", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1006780669"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/aje/kwm086", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1008224495"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nm0602-551b", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1009367418", 
          "https://doi.org/10.1038/nm0602-551b"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nm0602-551b", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1009367418", 
          "https://doi.org/10.1038/nm0602-551b"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/ijc.11350", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1019487370"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.bjc.6603633", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1026469206", 
          "https://doi.org/10.1038/sj.bjc.6603633"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1177/0272989x9701700414", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1027736952"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1177/0272989x9701700414", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1027736952"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1101/gr.1413403", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1028504395"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.vaccine.2007.05.058", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1030912520"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s1473-3099(07)70158-5", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1032791221"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/ijc.20396", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1034601191"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.bjc.6602580", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1036129550", 
          "https://doi.org/10.1038/sj.bjc.6602580"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.bjc.6602580", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1036129550", 
          "https://doi.org/10.1038/sj.bjc.6602580"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmoa021641", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1036284978"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/ijc.11334", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1040068020"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1048-891x.2004.014213.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1041366331"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmsa044278", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1042912539"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmsa044278", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1042912539"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1525-1438.2007.00827.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1046249780"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1525-1438.2007.00827.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1046249780"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.vaccine.2006.05.116", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1048761729"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.bjc.6602348", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1049714034", 
          "https://doi.org/10.1038/sj.bjc.6602348"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.bjc.6602348", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1049714034", 
          "https://doi.org/10.1038/sj.bjc.6602348"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/1478-7954-5-11", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1051176999", 
          "https://doi.org/10.1186/1478-7954-5-11"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.bjc.6604023", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1051357369", 
          "https://doi.org/10.1038/sj.bjc.6604023"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1074950205", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1077349395", 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2008-07", 
    "datePublishedReg": "2008-07-01", 
    "description": "Cervical cancer is a leading cause of cancer death among women in low-income countries, with approximately 25% of cases worldwide occurring in India. We estimated the potential health and economic impact of different cervical cancer prevention strategies. After empirically calibrating a cervical cancer model to country-specific epidemiologic data, we projected cancer incidence, life expectancy, and lifetime costs (I$2005), and calculated incremental cost-effectiveness ratios (I$/YLS) for the following strategies: pre-adolescent vaccination of girls before age 12, screening of women over age 30, and combined vaccination and screening. Screening differed by test (cytology, visual inspection, HPV DNA testing), number of clinical visits (1, 2 or 3), frequency (1 x , 2 x , 3 x per lifetime), and age range (35-45). Vaccine efficacy, coverage, and costs were varied in sensitivity analyses. Assuming 70% coverage, mean reduction in lifetime cancer risk was 44% (range, 28-57%) with HPV 16,18 vaccination alone, and 21-33% with screening three times per lifetime. Combining vaccination and screening three times per lifetime provided a mean reduction of 56% (vaccination plus 3-visit conventional cytology) to 63% (vaccination plus 2-visit HPV DNA testing). At a cost per vaccinated girl of I$10 (per dose cost of $2), pre-adolescent vaccination followed by screening three times per lifetime using either VIA or HPV DNA testing, would be considered cost-effective using the country's per capita gross domestic product (I$3452) as a threshold. In India, if high coverage of pre-adolescent girls with a low-cost HPV vaccine that provides long-term protection is achievable, vaccination followed by screening three times per lifetime is expected to reduce cancer deaths by half, and be cost-effective.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1038/sj.bjc.6604462", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": true, 
    "isFundedItemOf": [
      {
        "id": "sg:grant.6582558", 
        "type": "MonetaryGrant"
      }
    ], 
    "isPartOf": [
      {
        "id": "sg:journal.1017082", 
        "issn": [
          "0007-0920", 
          "1532-1827"
        ], 
        "name": "British Journal of Cancer", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "2", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "99"
      }
    ], 
    "name": "Health and economic impact of HPV 16 and 18 vaccination and cervical cancer screening in India", 
    "pagination": "6604462", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "b539f7c8dd8abe251c101f8a73bc7ce0043c6ac9cfeee2f51924002370ad7091"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "18612311"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "0370635"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1038/sj.bjc.6604462"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1038043563"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1038/sj.bjc.6604462", 
      "https://app.dimensions.ai/details/publication/pub.1038043563"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-10T19:45", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000001_0000000264/records_8681_00000425.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "http://www.nature.com/articles/6604462"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1038/sj.bjc.6604462'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1038/sj.bjc.6604462'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1038/sj.bjc.6604462'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1038/sj.bjc.6604462'


 

This table displays all metadata directly associated to this object as RDF triples.

266 TRIPLES      21 PREDICATES      68 URIs      37 LITERALS      25 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1038/sj.bjc.6604462 schema:about N03dd0cea95334866a59b495455a4dfd9
2 N0856628e68864a47bc24d1417f67593a
3 N10991a55b6484c5ba59f64b7eeaf35f8
4 N1a2825893e8149eb91ca3bda41412dba
5 N1e48a4e72c3344b5af08b1b01c7ab1e6
6 N32b607e617a941a0b1512be74d89d793
7 N396d32f698b447b0b053a8f3e47894d7
8 N503f9dfdbdaf4ec3a8bcf64c37eb9d9a
9 N6da0ed2a021044cebd2c03b49f8661d9
10 N86299bc331c44693842ecf198b4a63da
11 N8e10e8bdf361470995ef1261775122af
12 N8f831b7356af48fdb8ed70d862ed0c9c
13 N9843e541b8194eb5b114590ee036f303
14 Nc04d4ea19a544e44a5762ceb2d6f34f6
15 Nc68dfe193f1f4f50a7ef46e99c35cc16
16 Nee11e9c75e39411ebc1d94bc8d955576
17 anzsrc-for:11
18 anzsrc-for:1117
19 schema:author N3b922ce65a404a7bbc5b4a0c30af9efb
20 schema:citation sg:pub.10.1038/nm0602-551b
21 sg:pub.10.1038/sj.bjc.6602348
22 sg:pub.10.1038/sj.bjc.6602580
23 sg:pub.10.1038/sj.bjc.6603633
24 sg:pub.10.1038/sj.bjc.6604023
25 sg:pub.10.1186/1478-7954-5-11
26 https://app.dimensions.ai/details/publication/pub.1074950205
27 https://app.dimensions.ai/details/publication/pub.1077349395
28 https://doi.org/10.1002/ijc.11334
29 https://doi.org/10.1002/ijc.11350
30 https://doi.org/10.1002/ijc.20396
31 https://doi.org/10.1016/j.vaccine.2006.05.116
32 https://doi.org/10.1016/j.vaccine.2007.05.058
33 https://doi.org/10.1016/j.vaccine.2008.04.053
34 https://doi.org/10.1016/s0140-6736(07)61195-7
35 https://doi.org/10.1016/s1473-3099(07)70158-5
36 https://doi.org/10.1056/nejmoa021641
37 https://doi.org/10.1056/nejmsa044278
38 https://doi.org/10.1093/aje/kwm086
39 https://doi.org/10.1101/gr.1413403
40 https://doi.org/10.1111/j.1048-891x.2004.014213.x
41 https://doi.org/10.1111/j.1525-1438.2007.00827.x
42 https://doi.org/10.1177/0272989x9701700414
43 schema:datePublished 2008-07
44 schema:datePublishedReg 2008-07-01
45 schema:description Cervical cancer is a leading cause of cancer death among women in low-income countries, with approximately 25% of cases worldwide occurring in India. We estimated the potential health and economic impact of different cervical cancer prevention strategies. After empirically calibrating a cervical cancer model to country-specific epidemiologic data, we projected cancer incidence, life expectancy, and lifetime costs (I$2005), and calculated incremental cost-effectiveness ratios (I$/YLS) for the following strategies: pre-adolescent vaccination of girls before age 12, screening of women over age 30, and combined vaccination and screening. Screening differed by test (cytology, visual inspection, HPV DNA testing), number of clinical visits (1, 2 or 3), frequency (1 x , 2 x , 3 x per lifetime), and age range (35-45). Vaccine efficacy, coverage, and costs were varied in sensitivity analyses. Assuming 70% coverage, mean reduction in lifetime cancer risk was 44% (range, 28-57%) with HPV 16,18 vaccination alone, and 21-33% with screening three times per lifetime. Combining vaccination and screening three times per lifetime provided a mean reduction of 56% (vaccination plus 3-visit conventional cytology) to 63% (vaccination plus 2-visit HPV DNA testing). At a cost per vaccinated girl of I$10 (per dose cost of $2), pre-adolescent vaccination followed by screening three times per lifetime using either VIA or HPV DNA testing, would be considered cost-effective using the country's per capita gross domestic product (I$3452) as a threshold. In India, if high coverage of pre-adolescent girls with a low-cost HPV vaccine that provides long-term protection is achievable, vaccination followed by screening three times per lifetime is expected to reduce cancer deaths by half, and be cost-effective.
46 schema:genre research_article
47 schema:inLanguage en
48 schema:isAccessibleForFree true
49 schema:isPartOf N5217337509ad417a958770404a75a5c4
50 N73233a5081ed4484a4b71ebd5622fbb0
51 sg:journal.1017082
52 schema:name Health and economic impact of HPV 16 and 18 vaccination and cervical cancer screening in India
53 schema:pagination 6604462
54 schema:productId N0c88527c3c1942508755228588058482
55 N3677127d4cf943629d8be2519104c1ed
56 N798c5ad90d4a4340bfff2b7ca03ec2b0
57 N810d6c074fde4d269e9f2611b155f6cf
58 Nf90d2c513b984667ac4dfc54edd69f05
59 schema:sameAs https://app.dimensions.ai/details/publication/pub.1038043563
60 https://doi.org/10.1038/sj.bjc.6604462
61 schema:sdDatePublished 2019-04-10T19:45
62 schema:sdLicense https://scigraph.springernature.com/explorer/license/
63 schema:sdPublisher N362fbd0350584e908e3864e19469f141
64 schema:url http://www.nature.com/articles/6604462
65 sgo:license sg:explorer/license/
66 sgo:sdDataset articles
67 rdf:type schema:ScholarlyArticle
68 N03dd0cea95334866a59b495455a4dfd9 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
69 schema:name Risk Factors
70 rdf:type schema:DefinedTerm
71 N0856628e68864a47bc24d1417f67593a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
72 schema:name Mass Screening
73 rdf:type schema:DefinedTerm
74 N0c88527c3c1942508755228588058482 schema:name readcube_id
75 schema:value b539f7c8dd8abe251c101f8a73bc7ce0043c6ac9cfeee2f51924002370ad7091
76 rdf:type schema:PropertyValue
77 N10991a55b6484c5ba59f64b7eeaf35f8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
78 schema:name DNA, Viral
79 rdf:type schema:DefinedTerm
80 N163bcbc0d6c24b2d8c360d36b62613b5 rdf:first sg:person.010413204164.20
81 rdf:rest N98d86dd4a3d14cdb82ea962de8137e87
82 N1a2825893e8149eb91ca3bda41412dba schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
83 schema:name Humans
84 rdf:type schema:DefinedTerm
85 N1d5f4b18dba341a28f90b3a5b97ce5ef rdf:first sg:person.0670476071.20
86 rdf:rest rdf:nil
87 N1e48a4e72c3344b5af08b1b01c7ab1e6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
88 schema:name Models, Statistical
89 rdf:type schema:DefinedTerm
90 N283cef8ccf5c4014b886a9abecc3e8a2 rdf:first sg:person.015452603277.16
91 rdf:rest N7c921de8b68c4b66ac3d9f6e96b379a4
92 N32b607e617a941a0b1512be74d89d793 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
93 schema:name Female
94 rdf:type schema:DefinedTerm
95 N362fbd0350584e908e3864e19469f141 schema:name Springer Nature - SN SciGraph project
96 rdf:type schema:Organization
97 N3677127d4cf943629d8be2519104c1ed schema:name dimensions_id
98 schema:value pub.1038043563
99 rdf:type schema:PropertyValue
100 N396d32f698b447b0b053a8f3e47894d7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
101 schema:name Cost-Benefit Analysis
102 rdf:type schema:DefinedTerm
103 N3b922ce65a404a7bbc5b4a0c30af9efb rdf:first sg:person.0622362671.40
104 rdf:rest N163bcbc0d6c24b2d8c360d36b62613b5
105 N503f9dfdbdaf4ec3a8bcf64c37eb9d9a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
106 schema:name Models, Economic
107 rdf:type schema:DefinedTerm
108 N5217337509ad417a958770404a75a5c4 schema:volumeNumber 99
109 rdf:type schema:PublicationVolume
110 N6da0ed2a021044cebd2c03b49f8661d9 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
111 schema:name Human papillomavirus 16
112 rdf:type schema:DefinedTerm
113 N73233a5081ed4484a4b71ebd5622fbb0 schema:issueNumber 2
114 rdf:type schema:PublicationIssue
115 N798c5ad90d4a4340bfff2b7ca03ec2b0 schema:name doi
116 schema:value 10.1038/sj.bjc.6604462
117 rdf:type schema:PropertyValue
118 N7c921de8b68c4b66ac3d9f6e96b379a4 rdf:first sg:person.0725020131.22
119 rdf:rest Nc66766c535ae4ea38380ffdc2601c08e
120 N810d6c074fde4d269e9f2611b155f6cf schema:name nlm_unique_id
121 schema:value 0370635
122 rdf:type schema:PropertyValue
123 N86299bc331c44693842ecf198b4a63da schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
124 schema:name Uterine Cervical Neoplasms
125 rdf:type schema:DefinedTerm
126 N8e10e8bdf361470995ef1261775122af schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
127 schema:name India
128 rdf:type schema:DefinedTerm
129 N8f831b7356af48fdb8ed70d862ed0c9c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
130 schema:name Papillomavirus Vaccines
131 rdf:type schema:DefinedTerm
132 N9843e541b8194eb5b114590ee036f303 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
133 schema:name Vaccination
134 rdf:type schema:DefinedTerm
135 N98d86dd4a3d14cdb82ea962de8137e87 rdf:first sg:person.01001145477.44
136 rdf:rest N283cef8ccf5c4014b886a9abecc3e8a2
137 Nbff11e0b4c1746deac813ed7a79f8f85 schema:name Department of Health Policy and Management, Program in Health Decision Science, Harvard School of Public Health, 718 Huntington Avenue, 2nd Floor; Boston, MA 02115, USA
138 rdf:type schema:Organization
139 Nc04d4ea19a544e44a5762ceb2d6f34f6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
140 schema:name Stochastic Processes
141 rdf:type schema:DefinedTerm
142 Nc66766c535ae4ea38380ffdc2601c08e rdf:first sg:person.012346261072.25
143 rdf:rest N1d5f4b18dba341a28f90b3a5b97ce5ef
144 Nc68dfe193f1f4f50a7ef46e99c35cc16 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
145 schema:name Papillomavirus Infections
146 rdf:type schema:DefinedTerm
147 Nce01386c910f4166a5f0ad356a4b365e schema:name Department of Health Policy and Management, Program in Health Decision Science, Harvard School of Public Health, 718 Huntington Avenue, 2nd Floor; Boston, MA 02115, USA
148 rdf:type schema:Organization
149 Nee11e9c75e39411ebc1d94bc8d955576 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
150 schema:name Human papillomavirus 18
151 rdf:type schema:DefinedTerm
152 Nf90d2c513b984667ac4dfc54edd69f05 schema:name pubmed_id
153 schema:value 18612311
154 rdf:type schema:PropertyValue
155 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
156 schema:name Medical and Health Sciences
157 rdf:type schema:DefinedTerm
158 anzsrc-for:1117 schema:inDefinedTermSet anzsrc-for:
159 schema:name Public Health and Health Services
160 rdf:type schema:DefinedTerm
161 sg:grant.6582558 http://pending.schema.org/fundedItem sg:pub.10.1038/sj.bjc.6604462
162 rdf:type schema:MonetaryGrant
163 sg:journal.1017082 schema:issn 0007-0920
164 1532-1827
165 schema:name British Journal of Cancer
166 rdf:type schema:Periodical
167 sg:person.01001145477.44 schema:affiliation https://www.grid.ac/institutes/grid.418701.b
168 schema:familyName Albero
169 schema:givenName G
170 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01001145477.44
171 rdf:type schema:Person
172 sg:person.010413204164.20 schema:affiliation Nbff11e0b4c1746deac813ed7a79f8f85
173 schema:familyName Kim
174 schema:givenName J J
175 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010413204164.20
176 rdf:type schema:Person
177 sg:person.012346261072.25 schema:affiliation https://www.grid.ac/institutes/grid.418701.b
178 schema:familyName Bosch
179 schema:givenName F X
180 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012346261072.25
181 rdf:type schema:Person
182 sg:person.015452603277.16 schema:affiliation https://www.grid.ac/institutes/grid.418284.3
183 schema:familyName de Sanjosé
184 schema:givenName S
185 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015452603277.16
186 rdf:type schema:Person
187 sg:person.0622362671.40 schema:affiliation https://www.grid.ac/institutes/grid.7080.f
188 schema:familyName Diaz
189 schema:givenName M
190 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0622362671.40
191 rdf:type schema:Person
192 sg:person.0670476071.20 schema:affiliation Nce01386c910f4166a5f0ad356a4b365e
193 schema:familyName Goldie
194 schema:givenName S J
195 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0670476071.20
196 rdf:type schema:Person
197 sg:person.0725020131.22 schema:affiliation https://www.grid.ac/institutes/grid.17703.32
198 schema:familyName Clifford
199 schema:givenName G
200 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0725020131.22
201 rdf:type schema:Person
202 sg:pub.10.1038/nm0602-551b schema:sameAs https://app.dimensions.ai/details/publication/pub.1009367418
203 https://doi.org/10.1038/nm0602-551b
204 rdf:type schema:CreativeWork
205 sg:pub.10.1038/sj.bjc.6602348 schema:sameAs https://app.dimensions.ai/details/publication/pub.1049714034
206 https://doi.org/10.1038/sj.bjc.6602348
207 rdf:type schema:CreativeWork
208 sg:pub.10.1038/sj.bjc.6602580 schema:sameAs https://app.dimensions.ai/details/publication/pub.1036129550
209 https://doi.org/10.1038/sj.bjc.6602580
210 rdf:type schema:CreativeWork
211 sg:pub.10.1038/sj.bjc.6603633 schema:sameAs https://app.dimensions.ai/details/publication/pub.1026469206
212 https://doi.org/10.1038/sj.bjc.6603633
213 rdf:type schema:CreativeWork
214 sg:pub.10.1038/sj.bjc.6604023 schema:sameAs https://app.dimensions.ai/details/publication/pub.1051357369
215 https://doi.org/10.1038/sj.bjc.6604023
216 rdf:type schema:CreativeWork
217 sg:pub.10.1186/1478-7954-5-11 schema:sameAs https://app.dimensions.ai/details/publication/pub.1051176999
218 https://doi.org/10.1186/1478-7954-5-11
219 rdf:type schema:CreativeWork
220 https://app.dimensions.ai/details/publication/pub.1074950205 schema:CreativeWork
221 https://app.dimensions.ai/details/publication/pub.1077349395 schema:CreativeWork
222 https://doi.org/10.1002/ijc.11334 schema:sameAs https://app.dimensions.ai/details/publication/pub.1040068020
223 rdf:type schema:CreativeWork
224 https://doi.org/10.1002/ijc.11350 schema:sameAs https://app.dimensions.ai/details/publication/pub.1019487370
225 rdf:type schema:CreativeWork
226 https://doi.org/10.1002/ijc.20396 schema:sameAs https://app.dimensions.ai/details/publication/pub.1034601191
227 rdf:type schema:CreativeWork
228 https://doi.org/10.1016/j.vaccine.2006.05.116 schema:sameAs https://app.dimensions.ai/details/publication/pub.1048761729
229 rdf:type schema:CreativeWork
230 https://doi.org/10.1016/j.vaccine.2007.05.058 schema:sameAs https://app.dimensions.ai/details/publication/pub.1030912520
231 rdf:type schema:CreativeWork
232 https://doi.org/10.1016/j.vaccine.2008.04.053 schema:sameAs https://app.dimensions.ai/details/publication/pub.1005773753
233 rdf:type schema:CreativeWork
234 https://doi.org/10.1016/s0140-6736(07)61195-7 schema:sameAs https://app.dimensions.ai/details/publication/pub.1006780669
235 rdf:type schema:CreativeWork
236 https://doi.org/10.1016/s1473-3099(07)70158-5 schema:sameAs https://app.dimensions.ai/details/publication/pub.1032791221
237 rdf:type schema:CreativeWork
238 https://doi.org/10.1056/nejmoa021641 schema:sameAs https://app.dimensions.ai/details/publication/pub.1036284978
239 rdf:type schema:CreativeWork
240 https://doi.org/10.1056/nejmsa044278 schema:sameAs https://app.dimensions.ai/details/publication/pub.1042912539
241 rdf:type schema:CreativeWork
242 https://doi.org/10.1093/aje/kwm086 schema:sameAs https://app.dimensions.ai/details/publication/pub.1008224495
243 rdf:type schema:CreativeWork
244 https://doi.org/10.1101/gr.1413403 schema:sameAs https://app.dimensions.ai/details/publication/pub.1028504395
245 rdf:type schema:CreativeWork
246 https://doi.org/10.1111/j.1048-891x.2004.014213.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1041366331
247 rdf:type schema:CreativeWork
248 https://doi.org/10.1111/j.1525-1438.2007.00827.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1046249780
249 rdf:type schema:CreativeWork
250 https://doi.org/10.1177/0272989x9701700414 schema:sameAs https://app.dimensions.ai/details/publication/pub.1027736952
251 rdf:type schema:CreativeWork
252 https://www.grid.ac/institutes/grid.17703.32 schema:alternateName International Agency For Research On Cancer
253 schema:name Infections and Cancer Epidemiology Group, Epidemiology and Biology Cluster, International Agency for Research on Cancer (IARC), 150 Cours Albert Thomas, Lyon CEDEX 08 69372, France
254 rdf:type schema:Organization
255 https://www.grid.ac/institutes/grid.418284.3 schema:alternateName Institut d'Investigació Biomédica de Bellvitge
256 schema:name IDIBELL, CIBERESP, Barcelona, Spain
257 Unit of Infections and Cancer (UNIC), Cancer Epidemiology Research Programme, Catalan Institute of Oncology (ICO), Av. Gran Via, s/n km. 2.7, 08907 L'Hospitalet de Llobregat, Barcelona, Spain
258 rdf:type schema:Organization
259 https://www.grid.ac/institutes/grid.418701.b schema:alternateName Institut Català d'Oncologia
260 schema:name Unit of Infections and Cancer (UNIC), Cancer Epidemiology Research Programme, Catalan Institute of Oncology (ICO), Av. Gran Via, s/n km. 2.7, 08907 L'Hospitalet de Llobregat, Barcelona, Spain
261 rdf:type schema:Organization
262 https://www.grid.ac/institutes/grid.7080.f schema:alternateName Autonomous University of Barcelona
263 schema:name Department of Health Policy and Management, Program in Health Decision Science, Harvard School of Public Health, 718 Huntington Avenue, 2nd Floor; Boston, MA 02115, USA
264 Department of Paediatrics, Obstetrics, Gynaecology and Preventive Medicine, Program in Public Health and the Methodology of Biomedical Research, Universitat Autónoma de Barcelona (UAB), Bellaterra 08193 (Cerdanyola del Vallès), Spain
265 Unit of Infections and Cancer (UNIC), Cancer Epidemiology Research Programme, Catalan Institute of Oncology (ICO), Av. Gran Via, s/n km. 2.7, 08907 L'Hospitalet de Llobregat, Barcelona, Spain
266 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...